SURGICAL INNOVATIONS GROUP PLC

Board/Management Information • Apr 17, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5066C

Surgical Innovations Group PLC

17 April 2013

Surgical Innovations Group plc

("SI" or the "Company")

Appointment to the Clinical Advisory Board

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces the appointment of Consultant Thoracic Surgeon Marco Scarci to its Clinical Advisory Board ('CAB') with immediate effect.

Marco Scarci, MD, FRCS(Eng), is a Consultant Thoracic Surgeon specialising in video-assisted thoracoscopic surgery ('VATS') at Papworth Hospital NHS Foundation Trust. Marco undertook his specialist training in Italy, Malta, Essex Cardiothoracic Centre and Guy's and St Thomas' and completed his PostGraduate Certificate in Cardiothoracic Surgery in 2007. Marco is actively involved with the worldwide cardiothoracic surgery network (CTSNet), the Society of Cardiothoracic Surgeons and as a member of a the new technologies and Innovation workgroup and education and surgical manpower of the European Association for Cardiothoracic Surgery. He teaches and presents regularly at regional, national and international meetings (Royal Society of Medicine, Royal College Surgeons of England and European Association among others).

Marco's specialism is in VATS, which is a type of minimally invasive thoracic surgery performed using a small video camera. These procedures are a recent development within thoracic surgery and allow  surgeons to see inside the chest cavity after only making a small incision. This type of surgery benefits the patient in a number of ways including reduced  post operative pain, length of hospital stay and promotes a faster return to preoperative function

Graham Bowland, Chief Executive Officer for Surgical Innovations, said: "I am delighted to welcome Marco to the CAB.  Marco's expertise in MIS thoracic surgery will help us increase our awareness in this area. He is the first thoracic surgeon to join SI's CAB and reinforces our strategy to transfer our technology into new areas of the body.  We are delighted to welcome Marco to the CAB."

- ENDS -

Enquiries:

Surgical Innovations Group plc		www.sigroupplc.com
Doug Liversidge, Non-Executive Chairman	Tel: +44 (0) 113 230 7597
Graham Bowland, Chief Executive Officer	graham.bowland@surginno.co.uk
Panmure Gordon (Nominated Advisor & Broker)			www.panmure.com
Freddy Crossley (Corporate Finance)	Tel: +44 (0) 20 7886 2500
Adam Pollock/ Victoria Boxall (Corporate Broking)
Walbrook PR Ltd	Tel: +44 (0) 20 7933 8780
Paul McManus	Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com
Lianne Cawthorne	Mob: 07584 391 303 or lianne.cawthorne@walbrookpr.com

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

Over 100 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

The Group's patented products are sold through three main channels:

SI brand	Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent.
OEM and IP	The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion.
Industrial	SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime.

For more information, see www.sigrouplplc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCNKADQPBKDQQD